Peptide record

TPDB92544

Cyclo(L-Phe-Glu) or Dipeptide 4 Peptide 5b Anticancer Antihypertensive Umami Selfassembly modified_plain modified
2 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92544
Cyclo(L-Phe-Glu) or Dipeptide 4 Peptide 5b
Anticancer Antihypertensive Umami Selfassembly
Cardiometabolic peptides Cancer-related peptides Food sensory peptides Self-assembling and biomaterial peptides
CancerPPD 2.0 AHTPDB AHTpin Peptipedia Tastepeptides-Meta SAPdb
modified_plain
Yes
A 2-aa modified multi-activity (Anticancer, Antihypertensive, Umami, and other sources) peptide sequence curated from CancerPPD 2.0, AHTPDB, AHTpin, and other sources, with an available 3D structural model.
N-terminal: 4-azidobenzoic acid
Sequence
FE
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
2 reviewed residue count
Free Activity
L Activity
Linear Activity
4-azidobenzoic acid Activity
Antiproliferative, Anticancer Activity
Synthetic Activity
Self-Assembly Information 1 records
Record 1 Selfassembly

Source

23884374
10.1016/j.compbiomed.2021.104391
SAPdb: A database of short peptides and the corresponding nanostructures formed by self-assembly

Self-Assembly

Nanostructure formation
Hydrogel Transparent Hydrogel gel (Nanofibers)
pH: 6 solvent: Phosphate buffer (pH 6) concentration: 2% w/v
Selfassembly; Nanostructure=Hydrogel; Transparent Hydrogel gel (Nanofibers); Trigger=pH: 6; solvent: Phosphate buffer (pH 6); concentration: 2% w/v
Scanning Electron Microscopy (SEM)
Selfassembly
Evidence Records 4 records
Evidence 1 Activity

Activity

IC50
IC50 = 19.7 ± 0.06 µM
Anticancer
19.7

Target

Breast Cancer
MCF-7
Breast

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2017

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50 = 18.7 ± 0.04 µM
Anticancer
18.7

Target

Liver Cancer
HepG-2
Liver

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2017
Evidence 3 Activity

Activity

IC50
IC50 = 20.6 ± 0.04 µM
Anticancer
20.6

Target

Cervical Cancer
HeLa
Cervix

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2017
Evidence 4 Selfassembly

Activity

Nanostructure formation
Selfassembly Nanostructure=Hydrogel Transparent Hydrogel gel (Nanofibers) Trigger=pH: 6 solvent: Phosphate buffer (pH 6) concentration: 2% w/v
Hydrogel Transparent Hydrogel gel (Nanofibers)

Source & Reference

SAPdb
10.1016/j.compbiomed.2021.104391

Other

None specified
pH: 6 solvent: Phosphate buffer (pH 6) concentration: 2% w/v
Scanning Electron Microscopy (SEM)
23884374
SAPdb: A database of short peptides and the corresponding nanostructures formed by self-assembly
SAPdb ID NA low-detail seed row from experimentally curated self-assembly database.
Additional Detail Fields 5 fields
pH: 6 solvent: Phosphate buffer (pH 6) concentration: 2% w/v
None specified
SAPdb ID NA low-detail seed row from experimentally curated self-assembly database.
23884374
SAPdb: A database of short peptides and the corresponding nanostructures formed by self-assembly